doi: 10.3389/fphar.2022.1026182 Received 23 August 2022 Accepted 23 November 2022 Published 14 December 2022 Volume 13 - 2022 Edited by Junmin Zhang, Lanzhou University, China Reviewed by Yurong Lai, Gilead, United States Mei-Hua Qu, Weifang Second Peoples Hospital, China Updates Copyright 2022 He, Feng, Guo, Zhou, Li, Zhang, Zhang, Wang, Wang, Hao, Zhang, Gao, Gu, Zhang, Li and Li
Although further research is required in order to better understand its mechanisms and efficacy in practical settings, BPC 157 has the potential to be developed as a new therapy to conservatively treat or aid recovery following surgery in typically hypovascular and hypocellular soft tissues such as tendon and ligament tissue
Anyone using BPC-157 should monitor liver enzymes and kidney function and work with a provider
How long does BPC-157 take to work
For comparisons, final bacterial loads were normalized to untreated controls